Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class…
BioCina and NovaCina Merger Bolsters Global CDMO Industry
ADELAIDE, South Australia and PERTH, Western Australia, Jan. 13, 2025 /PRNewswire/ --…